These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27399311)

  • 41. False-positive results from colorectal cancer screening in Catalonia (Spain), 2000-2010.
    Garcia M; Milà N; Binefa G; Borràs JM; Espinàs JA; Moreno V
    J Med Screen; 2012 Jun; 19(2):77-82. PubMed ID: 22653571
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alerts in electronic medical records to promote a colorectal cancer screening programme: a cluster randomised controlled trial in primary care.
    Guiriguet C; Muñoz-Ortiz L; Burón A; Rivero I; Grau J; Vela-Vallespín C; Vilarrubí M; Torres M; Hernández C; Méndez-Boo L; Toràn P; Caballeria L; Macià F; Castells A
    Br J Gen Pract; 2016 Jul; 66(648):e483-90. PubMed ID: 27266861
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adding family history to faecal immunochemical testing increases the detection of advanced neoplasia in a colorectal cancer screening programme.
    Kallenberg FG; Vleugels JL; de Wijkerslooth TR; Stegeman I; Stoop EM; van Leerdam ME; Kuipers EJ; Bossuyt PM; Dekker E
    Aliment Pharmacol Ther; 2016 Jul; 44(1):88-96. PubMed ID: 27170502
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Second-Look Colonoscopies and the Impact on Capacity in FIT-Based Colorectal Cancer Screening.
    Grobbee EJ; Kapidzic A; van Vuuren AJ; van Leerdam M; Lansdorp-Vogelaar I; Looman CW; Bruno MJ; Kuipers EJ; Spaander MC
    Am J Gastroenterol; 2015 Jul; 110(7):1072-7. PubMed ID: 26054624
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Colorectal cancer in a second round after a negative faecal immunochemical test.
    Bujanda L; Sarasqueta C; Castells A; Pellisé M; Cubiella J; Gil I; Cosme A; Arana-Arri E; Mar I; Idigoras I; Portillo I;
    Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):813-8. PubMed ID: 25856688
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current screening guidelines overlook a significant number of patients treated for colorectal cancer.
    Przybyla AG; Crockett JA; Rex JC; Culumovic PJ
    Am Surg; 2014 Jun; 80(6):539-43. PubMed ID: 24887789
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Against colorectal cancer in our neighborhoods (ACCION): A comprehensive community-wide colorectal cancer screening intervention for the uninsured in a predominantly Hispanic community.
    Shokar NK; Byrd T; Salaiz R; Flores S; Chaparro M; Calderon-Mora J; Reininger B; Dwivedi A
    Prev Med; 2016 Oct; 91():273-280. PubMed ID: 27575314
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Faecal occult blood testing screening for colorectal cancer and 'missed' interval cancers: are we ignoring the elephant in the room? Results of a multicentre study.
    George AT; Aggarwal S; Dharmavaram S; Menon A; Dube M; Vogler M; Field A
    Colorectal Dis; 2017 May; 19(5):O108-O114. PubMed ID: 27992095
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up.
    Scholefield JH; Moss SM; Mangham CM; Whynes DK; Hardcastle JD
    Gut; 2012 Jul; 61(7):1036-40. PubMed ID: 22052062
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Screen detection is a survival predictor independent of pathological grade in colorectal cancer. A prospective cohort study.
    Chan YM; MacKay C; Ritchie DT; Scott N; Parnaby C; Murray GI; Ramsay G
    Surgeon; 2021 Feb; 19(1):20-26. PubMed ID: 32229071
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Community-based survey of knowledge of, attitudes to and practice of colorectal cancer screening in Hong Kong.
    Wong GCY; Lee KY; Lam KF; Fan SYS
    J Dig Dis; 2017 Oct; 18(10):582-590. PubMed ID: 28945312
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting.
    Chen H; Werner S; Butt J; Zörnig I; Knebel P; Michel A; Eichmüller SB; Jäger D; Waterboer T; Pawlita M; Brenner H
    Oncotarget; 2016 Mar; 7(13):16420-32. PubMed ID: 26909861
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk stratification and detection of new colorectal neoplasms after colorectal cancer screening with faecal occult blood test: experiences from a Danish screening cohort.
    Bjerrum A; Milter MC; Andersen O; Fischer A; Lynge E
    Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1433-7. PubMed ID: 26352132
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Colonoscopic surveillance of first-degree relatives of colorectal cancer patients in a faecal occult blood screening programme.
    Sassoli de Bianchi P; Campari C; Mancini S; Giuliani O; Landi P; Paterlini L; Naldoni C; Finarelli AC; Falcini F; Ponz de Leon M; Sassatelli R; Borciani E; Fornari F; Gatti G; Zatelli M; Zurlini C; Rossi F; Corradini R; Olivetti R; Manfredi M; Baldazzi P; Nannini R; Zanarini S; Matarese VG; Palmonari C; Triossi O; Gordini S; Vattiato R; Colamartini A; Palazzi M; Severi M; Briganti L; Giovanardi M; Casale C; Bucchi L
    Cancer Epidemiol; 2013 Aug; 37(4):469-73. PubMed ID: 23683843
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Round one of the Adelaide and Meath Hospital/Trinity College Colorectal Cancer Screening Programme: programme report and analysis based on established international key performance indices.
    McNamara D; Qasim A; Lee N; Condon C; O'Morain C
    Ir J Med Sci; 2011 Jun; 180(2):549-52. PubMed ID: 21264524
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
    Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
    Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Results of the Czech National Colorectal Cancer Screening Programme - colonoscopy examinations].
    Suchánek S; Májek O; Zavoral M; Seifert B; Ngo O; Dušek L
    Klin Onkol; 2014; 27 Suppl 2():98-105. PubMed ID: 25494894
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Colorectal cancer screening in an expanding panorama of screening programmes.
    Hoff G
    Best Pract Res Clin Gastroenterol; 2010 Aug; 24(4):521-7. PubMed ID: 20833354
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.
    Denters MJ; Deutekom M; Bossuyt PM; Stroobants AK; Fockens P; Dekker E
    Gastroenterology; 2012 Mar; 142(3):497-504. PubMed ID: 22108194
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Efficacy of the population-based pilot colorectal screening program. Hungary, Csongrád county, 2015].
    Rutka M; Molnár T; Bor R; Farkas K; Fábián A; Győrfi M; Bálint A; Milassin Á; Szűcs M; Tiszlavicz L; Nagy F; Szepes Z
    Orv Hetil; 2017 Oct; 158(42):1658-1667. PubMed ID: 29037058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.